• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Estimating myocardial fibrosis in aortic stenosis using the serum collagen type I C-terminal telopeptide to matrix metalloproteinase-1 ratio.

作者信息

Gersch Svante, Bengel Philipp, Paul Niels B, Ravassa Susana, von Haehling Stephan, Fischer Andreas, Zeisberg Elisabeth M, Puls Miriam, Hasenfuß Gerd, Schnelle Moritz

机构信息

Department of Clinical Chemistry Department of Cardiology and Pneumology University Medical Center Göttingen Göttingen Germany.

Program of Cardiovascular Disease Centro de Investigacion Medica Aplicada Universidad de Navarra (CIMA) Pamplona Spain.

出版信息

MedComm (2020). 2025 Jan 16;6(2):e70069. doi: 10.1002/mco2.70069. eCollection 2025 Feb.

DOI:10.1002/mco2.70069
PMID:39830018
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11739461/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de4d/11739461/4e591fe5c63b/MCO2-6-e70069-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de4d/11739461/4e591fe5c63b/MCO2-6-e70069-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de4d/11739461/4e591fe5c63b/MCO2-6-e70069-g001.jpg

相似文献

1
Estimating myocardial fibrosis in aortic stenosis using the serum collagen type I C-terminal telopeptide to matrix metalloproteinase-1 ratio.利用血清I型胶原C末端肽与基质金属蛋白酶-1的比值评估主动脉瓣狭窄中的心肌纤维化。
MedComm (2020). 2025 Jan 16;6(2):e70069. doi: 10.1002/mco2.70069. eCollection 2025 Feb.
2
Circulating collagen metabolites, myocardial fibrosis and heart failure in aortic valve stenosis.主动脉瓣狭窄时循环中的胶原代谢产物、心肌纤维化与心力衰竭
J Heart Valve Dis. 2013 Mar;22(2):166-76.
3
Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial.基于生物标志物的心肌纤维化表型分析鉴定出射血分数保留的心力衰竭患者对螺内酯有益作用的抵抗：来自 Aldo-DHF 试验的结果。
Eur J Heart Fail. 2018 Sep;20(9):1290-1299. doi: 10.1002/ejhf.1194. Epub 2018 Apr 30.
4
The definition of fibrogenic processes in fibroblastic foci of idiopathic pulmonary fibrosis based on morphometric quantification of extracellular matrices.基于细胞外基质形态计量学定量分析的特发性肺纤维化成纤维细胞灶中纤维化过程的定义。
Hum Pathol. 2009 Sep;40(9):1278-87. doi: 10.1016/j.humpath.2009.01.014. Epub 2009 Apr 22.
5
Atrial matrix remodeling in atrial fibrillation patients with aortic stenosis.心房基质重构在主动脉瓣狭窄伴心房颤动患者中的研究。
BMC Cardiovasc Disord. 2020 Oct 31;20(1):468. doi: 10.1186/s12872-020-01754-0.
6
Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction.舒张性心力衰竭：心肌胶原转换增加与舒张功能障碍相关的证据。
Circulation. 2007 Feb 20;115(7):888-95. doi: 10.1161/CIRCULATIONAHA.106.638569. Epub 2007 Feb 5.
7
Atorvastatin reduces myocardial fibrosis in a rat model with post-myocardial infarction heart failure by increasing the matrix metalloproteinase-2/tissue matrix metalloproteinase inhibitor-2 ratio.阿托伐他汀通过增加基质金属蛋白酶-2/组织基质金属蛋白酶抑制剂-2 比值减少心肌梗死后心力衰竭大鼠的心肌纤维化。
Chin Med J (Engl). 2013;126(11):2149-56.
8
Combination of Circulating Type I Collagen-Related Biomarkers Is Associated With Atrial Fibrillation.循环 I 型胶原相关生物标志物的组合与心房颤动有关。
J Am Coll Cardiol. 2019 Apr 2;73(12):1398-1410. doi: 10.1016/j.jacc.2018.12.074.
9
Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.主动脉反流性心脏中基质金属蛋白酶、组织抑制剂的差异表达及细胞外基质重塑
Cardiology. 2009;113(3):161-8. doi: 10.1159/000187723. Epub 2009 Jan 8.
10
Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover.阵发性和持续性心房颤动患者的细胞外基质改变：I型胶原周转的生化评估
J Am Coll Cardiol. 2008 Jul 15;52(3):211-5. doi: 10.1016/j.jacc.2008.03.045.

本文引用的文献

1
Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial.基于生物标志物的胶原交联评估可识别出更有可能从螺内酯对左心房重构的影响中获益的心力衰竭风险患者。来自 HOMAGE 临床试验的见解。
Eur J Heart Fail. 2022 Feb;24(2):321-331. doi: 10.1002/ejhf.2394. Epub 2021 Dec 9.
2
Impact of myocardial fibrosis on left ventricular remodelling, recovery, and outcome after transcatheter aortic valve implantation in different haemodynamic subtypes of severe aortic stenosis.在严重主动脉瓣狭窄的不同血流动力学亚型中，心肌纤维化对经导管主动脉瓣植入术后左心室重构、恢复及预后的影响。
Eur Heart J. 2020 May 21;41(20):1903-1914. doi: 10.1093/eurheartj/ehaa033.
3
Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial.基于生物标志物的心肌纤维化表型分析鉴定出射血分数保留的心力衰竭患者对螺内酯有益作用的抵抗：来自 Aldo-DHF 试验的结果。
Eur J Heart Fail. 2018 Sep;20(9):1290-1299. doi: 10.1002/ejhf.1194. Epub 2018 Apr 30.
4
Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure.心肌胶原交联与高血压性心力衰竭患者心力衰竭住院相关。
J Am Coll Cardiol. 2016 Jan 26;67(3):251-60. doi: 10.1016/j.jacc.2015.10.063.
5
Circulating Biomarkers of Myocardial Fibrosis: The Need for a Reappraisal.循环心肌纤维化生物标志物：重新评估的必要性。
J Am Coll Cardiol. 2015 Jun 9;65(22):2449-56. doi: 10.1016/j.jacc.2015.04.026.